Morgan Stanley has recently initiated Recursion Pharmaceuticals Inc (RXRX) stock rating, as announced on May 22, 2023, according to Finviz. Earlier, on March 16, 2023, Needham had initiated the stock ...

On Thursday, Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $1.59 which represents a slight increase of $0.05 or 3.25% from the prior close of $1.54. The stock opened at $1.54 and ...

Analysts at SVB Leerink rounded up the five best and the five worst acquisitions of the last decade. The list of best and worst deals are based on an analysis of all the transactions over the last ...

Fireside chat with Frank Nestle, Global Head of Research & Chief Scientific Officer (3:00 p.m ET / 9:00 p.m CET) ...

Andrew has previously held senior roles at SVB Leerink, MTS Health Partners, Torreya Partners, and Cowen & Company. Andrew is a graduate of the Wharton School at the University of Pennsylvania.

The BUY prediction by SVB_Leerink_LLC shows slight gains of 7.44%. This prediction currently runs until 07.10.25. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC ...